Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EOS imaging: First EOSedgeTM Installation in Australia
EOS imaging: First EOSedgeTM Installation in Australia


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - PEA-PME eligible), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

Humana, Humana Foundation Commit More Than $1 Million to COVID-19 Relief and Recovery Efforts in Georgia
Humana, Humana Foundation Commit More Than $1 Million to COVID-19 Relief and Recovery Efforts in Georgia


Together, Humana Inc. (NYSE: HUM) and the company’s philanthropic arm, The Humana Foundation, have committed more than $1 million in COVID-19 relief for communities in Georgia to date.



“The

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020
CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020


The table in the release was incorrect. The corrected table should read:



PerkinElmer, Inc:

PerkinElmer, Inc. and SubsidiariesRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)

No Brainer Club: Ex-Empfehlung mit +2.409% in 7 Monaten
No Brainer Club: Ex-Empfehlung mit +2.409% in 7 Monaten

Cardiff Oncology (WKN: A2P4GU) ist einer der diesjährigen Überflieger an der Nasdaq. Seit ihrem Jahrestief bei 0,70 USD steht für die Aktie eine gigantische Performance von +2.409% in nur sieben

Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases


Agilent Technologies Inc. (NYSE: A) today announced the expansion of Visiopharm’s validated image analysis algorithm to incorporate HercepTest™ mAb pharmDx for Dako Omnis, both CE-IVD marked and

Humana Expanding in New Jersey, Will Sell Medicare Advantage Plans in Four More Counties
Humana Expanding in New Jersey, Will Sell Medicare Advantage Plans in Four More Counties


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today it will grow its New Jersey market footprint by offering Medicare Advantage plans in four additional counties in the

Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress
Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Diagnostics AB, and a global leader in the

NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public

Humana Medicare Advantage Members Benefit From Improved Health Outcomes, Preventive Care and an Estimated $4 Billion in Reduced Costs Through Value-Based Care
Humana Medicare Advantage Members Benefit From Improved Health Outcomes, Preventive Care and an Estimated $4 Billion in Reduced Costs Through Value-Based Care


Humana Inc. (NYSE: HUM) unveiled today its annual Value-based Care Report, detailing that 2.41 million Humana individual Medicare Advantage beneficiaries receiving care from primary care physicians

NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today provided preliminary financial and operational highlights for

NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies Announces Commencement of Public Offering of Common Stock


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it intends to offer and sell, subject to market

Centura Health and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in Colorado Springs
Centura Health and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in Colorado Springs


Centura Health and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement in Colorado Springs, expanding access to care for Humana Medicare members.

Grand View Health and Humana Sign Medicare Network Agreement in Pennsylvania
Grand View Health and Humana Sign Medicare Network Agreement in Pennsylvania


Community health system Grand View Health and leading health and well-being company Humana Inc. (NYSE: HUM) have signed an agreement that will provide in-network access for Humana Medicare

NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release third quarter 2020

Quidel Receives Emergency Authorization for First Rapid Antigen “ABC Test”: A Combination Diagnostic Assay for Influenza A+B and COVID-19
Quidel Receives Emergency Authorization for First Rapid Antigen “ABC Test”: A Combination Diagnostic Assay for Influenza A+B and COVID-19


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has

Quidel Announces Preliminary Revenue for Third Quarter 2020
Quidel Announces Preliminary Revenue for Third Quarter 2020


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects

Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.
Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020. Management will hold a conference call

Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.
Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020. Management will hold a conference call

Humana Rolls Out 2021 Medicare Advantage Health Plans with Expanded $0 Premiums and Enhanced Benefits in More Counties Nationwide
Humana Rolls Out 2021 Medicare Advantage Health Plans with Expanded $0 Premiums and Enhanced Benefits in More Counties Nationwide


Humana Inc. (NYSE: HUM) today announced details of its 2021 Medicare product offerings, including Medicare Advantage and Prescription Drug Plans that are built with the benefits and options people

University of Toledo Medical Center, University of Toledo Physicians Sign Network Agreements with Humana
University of Toledo Medical Center, University of Toledo Physicians Sign Network Agreements with Humana


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today it has signed Medicare and commercial plan network agreements with University of Toledo Medical Center (UTMC) and

Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent
Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture

Acadia Healthcare Announces Pricing of $475 Million Senior Notes Due 2029
Acadia Healthcare Announces Pricing of $475 Million Senior Notes Due 2029


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its previously announced private offering (the “Offering”) of $475 million in aggregate

Rush Health and Humana Sign Medicare Network Agreement
Rush Health and Humana Sign Medicare Network Agreement


Clinically-integrated physician and hospital network Rush Health and leading health and well-being company Humana Inc. (NYSE: HUM) today announced an agreement to expand access to quality

Acadia Healthcare Announces Launch of $475 Million Senior Notes Offering
Acadia Healthcare Announces Launch of $475 Million Senior Notes Offering


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2029 (the “Notes”), subject